TransMedics Group Investors Urged to Seek Counsel Before Critical Deadline in Securities Lawsuit

Rosen Top-Ranked Investor Counsel Encourages TransMedics Group Inc. Investors to Secure Counsel Before Deadline

Chicago, IL - Rosen Law Firm, a top-ranked investor counsel, is urging investors who purchased shares of TransMedics Group Inc. (NASDAQ: TRMC) to secure counsel before the deadline to file a lead plaintiff motion in this class action lawsuit.

On March 3, 2023, TransMedics Group Inc. announced that it would be acquired by Stryker Corporation. The Rosen Law Firm is investigating claims that the company and its officers made false and/or misleading statements and/or omitted to state material information, in violation of federal securities laws.

The investigation seeks to determine whether the company's officers and directors failed to provide investors with accurate and timely information about the company's business and financial condition, leading to artificially inflated stock prices. The investigation also seeks to determine whether the company's officers and directors engaged in any illegal activities, such as insider trading or manipulating the company's stock price.

Investors who purchased shares of TransMedics Group Inc. during the class period are encouraged to contact the Rosen Law Firm to discuss their legal rights and options. The deadline to file a lead plaintiff motion is [insert deadline].

The Rosen Law Firm is a nationally recognized investor counsel with a long history of success in representing investors in securities class actions. The firm's attorneys have extensive experience in litigating complex securities cases and have recovered hundreds of millions of dollars for investors.

For more information, please contact:

Rosen Law Firm 2350 N. Lincoln Park Ave, Suite 300 Chicago, IL 60614 Phone: (866) 767-3653 Email: info@rosenlegal.com